The digital health financing market has been very high in the last five years. As this roller coaster begins to settle, one thing is clear for Randy Bolyga: that the industry is changing towards the prioritization of profitability over aggressive expansion.
Bolyga is the CEO of the RXNT medical software company, which founded in 1999. The company began selling electronic recipe software, but since then it has grown to provide a complete set of tools for things such as the management of practice, billing and programming.
RXNT is “a starting company”, cordination to Bolyga. RXNT started taking two small businesses from $ 150,000 (SBA), and paid them in three years.
“We have a positive and debt cash since we are somewhere between $ 60-75 million in revenue this year and 50% Ebitda,” Bolyga said.
He thinks that an important reason for the success of the company is the fact that he has never trusted the risk capital.
At the beginning of the 2000s, when Rxnt was fresh in the health technology scene, many of the company’s competitors went after the risk capital and brought billionaire funds, Bolyga said.
Many of these companies had “crazy burning rates,” he added. In other words, these companies were spending huge amounts of money very quickly, or dozens of millions of dollars a year, in an effort to grow rapidly.
“That is the son of the formula that VCS draws in front of you,” Bolyga said.
He stressed that medical care is a complex and entrenched industry, and that success requires a strong understanding of workflows and customer needs.
Risk capital investors also or misunderstand the health market, assuming that an innovative feature is sufficient to win customers, Bolyga said. The striking criticized AI tools that are not integrated into the provider’s workflows, saying that they will have difficulty obtaining adoption.
He believes in a “turtle about his” approach: a slow, stable and fiscally conservative growth. He said he has also seen Seny that many companies “crash and burn.” They pursued rapid expansion without sustainable commercial models or a deep understanding of the market.
However, Bolyga acknowledged that risk capital can make sense for new companies in the niche of markets that need a fast scale, but warned that it should be the exception, not the standard.
In general, Bolyga sees a change throughout the industry from growth in all costs to prioritization of profitability and sustainability. Even investors now demand more discipline and responsibility on the expenses side, and new companies now have to demonstrate that they can achieve specific objectives and develop reliable income flows that are large rounds of financing, he said.
Photo: Phive2015, Getty Images